Awake Prone Positioning for COVID-19 Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis of Randomized Trials

Abstract

<b>Background and Rationale:</b> The benefits of awake prone positioning (APP) in patients with hypoxemic respiratory failure due to Coronavirus disease 2019 (COVID-19) remain uncertain. This systematic review and meta-analysis aimed to determine the efficacy and safety of&nbsp;APP versus usual care in non-intubated adults with COVID-19 hypoxemic respiratory failure. <b>Methods:</b> We searched MEDLINE, Embase and CENTRAL for randomized trials on APP for hypoxemic respiratory failure. The primary outcome was endotracheal intubation. Secondary outcomes were mortality, ventilator-free days, intensive care unit and hospital length of stay, escalation of oxygen modality, change in oxygenation and respiratory rate, and adverse events. Random-effects meta-analysis was performed for the primary and secondary outcomes. Bayesian meta-analysis was performed for endotracheal intubation and mortality outcomes. <b>Results:</b> Seventeen trials (2931 patients) met eligibility criteria. APP, versus usual care, reduced the risk of intubation (24.2% vs 29.8%, relative risk [RR] 0.83, 95% Confidence Interval [CI] 0.73-0.94; I²=0%, high certainty). APP did not significantly affect mortality or other secondary outcomes.&nbsp;Bayesian meta-analysis using non-informative priors&nbsp;found a high probability of benefit with&nbsp;APP for intubation (mean RR of 0.84, 95% Credible Interval [CrI] 0.72 to 0.97; posterior probability for RR &lt;1 of 0.99) but not for mortality (mean RR of 0.94, 95% CrI 0.78 to 1.14: posterior probability for RR &lt;1 of 0.75). <b>Conclusion:</b> APP reduces the risk of intubation versus usual care in patients with COVID-19 but did not&nbsp;improve mortality or other secondary outcomes.